Apixaban serves as a selective factor Xa inhibitor for stroke prevention. Biochemical modulation of the coagulation cascade prevents clot generation, assisting in the management of venous thromboembolic clinical scenarios.
Targeting clotting pathways, apixaban belongs to the direct factor Xa inhibitor class. This chemical interrupts a key step in the cascade that forms blood clots, helping to keep circulation clear. In Singapore, the active compound appears in the brand-name medicine Eliquis and several generic equivalents. Patients often encounter it when clinicians aim to reduce the risk of clot-related events.
Formulated for oral use, the substance is supplied primarily as film-coated tablets. The 2.5 mg and 5 mg strengths allow flexibility for different treatment plans. Both branded and generic tablets meet the Health Sciences Authority’s quality standards, and they are distributed through hospitals and community pharmacies. Occasionally, an oral suspension is prepared for individuals who cannot swallow pills.
Addressing clot-related conditions, the drug is employed to prevent stroke in people with non-valvular atrial fibrillation. It also assists in treating deep-vein thrombosis and pulmonary embolism, and it helps prevent recurrence after an initial clot event. Typical users include adults with irregular heart rhythms, those recovering from leg or lung clots, and patients at heightened risk due to limited mobility.
Interrupting the final step that converts pro-thrombin to thrombin, the agent reduces the formation of fibrin strands that solidify clots. By limiting factor Xa activity, it gently slows the clotting cascade without stopping it entirely. This selective action allows normal clotting for minor injuries while lowering the chance of dangerous blockages in arteries and veins.
Experiencing mild bruising or nosebleeds may occur as the blood’s clotting capacity is reduced.
Developing sudden severe bleeding, such as in the gastrointestinal tract or brain, signals an urgent medical situation.
Avoiding use is recommended for individuals with active major bleeding, severe liver disease, or during pregnancy.
Checking for interactions with alcohol, certain antifungals, and other anticoagulant agents helps prevent unexpected effects; always refer to the specific medication’s insert for a complete list.
Storing tablets in a cool, dry place protects their potency, and keeping the bottle tightly closed guards against moisture. Treatment length varies: some patients take the medicine for a few months after a clot, while others use it long-term for rhythm-related stroke prevention. Different Eliquis formulations may differ in tablet size or scoring, so follow the product’s packaging for exact handling instructions. For detailed usage, dosing, and administration, refer to the specific medication’s clinical information.
This educational overview of apixaban is not medical advice; individual medicines such as Eliquis differ in strength, formulation, and instructions. The information provided does not create liability for clinical application. Patients should read the specific medication labeling and discuss any concerns with a licensed healthcare professional.
